Description and Modeling of Relevant Demographic and Laboratory Variables in a Large Oncology Cohort to Generate Virtual Populations by Laura Pérez-Ramos, Laura Ibarra-Gómez, Rubin Lubomirov, María García-Cremades, Eduardo Asín-Prieto, Salvador Fudio, Pablo Zubiaur

Subjects: “…pharmacometrics…”
Get full text

An integrated population pharmacokinetic model of febuxostat in pediatric patients with hyperuricemia including gout and adult population of healthy subjects and patients with rena... by Ryutaro Iwama, Kimie Nishida, Daisuke Ishii, Takeshi Iijima

Subjects: Get full text

Potential serotype-specific effectiveness against IPD of pneumococcal conjugate vaccines V114 and PCV20 in children given a 2+1 dosing regimen by Josiah Ryman, Jeffrey R. Sachs, Natalie Banniettis, Thomas Weiss, Maurice Ahsman, Ka Lai Yee, Jessica Weaver

Subjects: Get full text

Impact of using time-averaged exposure metrics on binary endpoints in exposure-response analyses by Yu-Wei Lin, Yu-Wei Lin, Yu-Wei Lin, Yu-Wei Lin, Yu-Wei Lin, Anna Largajolli, Anna Largajolli, A. Yin Edwards, A. Yin Edwards, S. Y. Amy Cheung, S. Y. Amy Cheung, Kashyap Patel, Stefanie Hennig, Stefanie Hennig

Subjects: Get full text

Model-informed drug discovery and development approaches to inform clinical trial design and regulatory decisions: A primer for the MENA region by Mohammed S. Alasmari, Salwa Albusaysi, Marwa Elhefnawy, Ali M. Ali, Khalid Altigani, Mohammed Almoslem, Mohammed Alharbi, Jahad Alghamdi, Abdullah Alsultan

Subjects: Get full text

The Role of Pharmacometrics in Advancing the Therapies for Autoimmune Diseases by Artur Świerczek, Dominika Batko, Elżbieta Wyska

Subjects: “…pharmacometrics…”
Get full text